Close

Synergy Pharmaceuticals (SGYP) Closes Plecanatide Phase 2b Enrollment

December 24, 2013 6:22 AM EST Send to a Friend
Synergy Pharmaceuticals Inc. (Nasdaq: SGYP) announced it has closed patient enrollment in its plecanatide phase 2b clinical trial in irritable ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login